Insmed Incorporated Stock Performance
as on March 21, 2026 at 6:59 am IST
Day's Low
Day's High
$135.73$143.60
0.18%
Downside
5.61%
Upside
52 Week's Low
52 Week's High
$60.40$212.7555.58%
Downside
56.47%
Upside
Insmed Incorporated share price movements today
- Previous Close
- $144.00
- Open
- $142.74
- Volume
- 1.4M
- Day's Low - High
- $135.73 - $143.60
- 52 Week Low - High
- $60.40 - $212.75
Insmed Incorporated Historical Returns
- 1 Month Return
- -17.53 %
- 3 Month Return
- -22.21 %
- 1 Year Return
- + 70.17 %
- 3 Year Return
- + 705.69 %
- 5 Year Return
- + 262.47 %
Insmed Incorporated Stock Fundamentals & Key Indicators
Check Insmed Incorporated market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$29.3B
EPS (TTM)
-2.8484
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
0.00%
PE Ratio (TTM)
-16.34
Industry PE ratio
17.63179487179487
PEG Ratio
1.0916
EBITDA
-980.5M
Revenue (TTM)
606.4M
Profit Margin
-210.54%
Return On Equity TTM
-249.28%
Insmed Incorporated Stock Valuation
Track how Insmed Incorporated P/E has moved over time to understand its valuation trends.
Insmed Incorporated in the last 5 years
Lowest (-28.47x)
December 31, 2025
Today (-16.34x)
March 21, 2026
Industry (17.63x)
March 21, 2026
Highest (-3.61x)
June 30, 2023
Today’s Price to Earnings Ratio: -16.34x
Insmed Incorporated vs Peer Comparison
Compare market cap, revenue, PE, and other key metrics of Insmed Incorporated with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
|---|---|---|---|---|---|
| BUY | $29.3B | 262.47% | -16.34 | -210.54% | |
| BUY | $41.3B | 116.54% | 133.52 | 8.45% | |
| BUY | $116.3B | 110.08% | 29.94 | 32.94% | |
| NA | $32.5B | NA | 114.93 | 5.37% | |
| BUY | $78.0B | 54.71% | 17.8 | 31.41% |
Stock Returns calculator for Insmed Incorporated Stock including INR - Dollar returns
The Insmed Incorporated stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Insmed Incorporated investment value today
Current value as on today
₹1,79,037
Returns
₹79,037
(+79.04%)
Returns from Insmed Incorporated Stock
₹70,133 (+70.13%)
Dollar Returns*
₹8,904 (+8.9%)
Analyst Recommendation on Insmed Incorporated Stock
Based on 23 analysts
95.65%
Buy
4.35%
Hold
0.00%
Sell
Based on 23 analysts, 95.65% of analysts recommend a 'BUY' rating for Insmed Incorporated. Average target price of $213
Insmed Incorporated Share Price Target
Get share price movements and forecasts by analysts on Insmed Incorporated.
What analysts predicted
36.16%UPSIDE
Target Price
$213
Current Price
$135.97
Analyzed by
23 Analysts
Target
$213.00
Insmed Incorporated target price $213, a slight upside of 36.16% compared to current price of $135.97. According to 23 analysts rating.
Insmed Incorporated Stock’s Investor Sentiment and Interest
Search interest for Insmed Incorporated Stock has decreased by -2% in the last 30 days, reflecting a downward trend in search activity.
Time period: to
Insmed Incorporated Quarterly Profit & Loss
All numbers in Millions USD
Insmed Incorporated Annual Profit & Loss
All numbers in Millions USD
Insmed Incorporated Quarterly Cash Flow
All numbers in Millions USD
Insmed Incorporated Annual Cash Flow
All numbers in Millions USD
Mutual Funds that own Insmed Incorporated Stock
Check out the Mutual Funds with significant holdings in Insmed Incorporated.
Funds | Holdings | Shares Held |
|---|---|---|
 ICICI Prudential NASDAQ 100 Index Fund Direct Growth | 0.17108% | 3528 |
Global Institutional Holdings in Insmed Incorporated
Insmed Incorporated News & Key Events
Today's Timeline - 18 December
Thu, 04:44 PM
-Insmed discontinues development of brensocatib for rhinosinusitis after failing to meet endpoints; shares slide 19%.
Thu, 11:00 PM
-Insmed stock falls 15.28% after Phase 2b study results for brensocatib fail to meet efficacy endpoints.
Insights on Insmed Incorporated
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
POSITIVE IMPACTRevenue Rich
Insmed Incorporated has shown strong revenue growth over the past four quarters. Their revenue increased from $92.82 million to $263.84 million, averaging a growth of 28.1% each quarter.
- POSITIVE IMPACT
Profit Spike
Insmed Incorporated has seen an improvement in its net profit over the last two quarters. The net profit increased from -370.02 million dollars to -328.48 million dollars. This represents an average increase of 12.6% per quarter.
- POSITIVE IMPACT
Price Rise
In the last 3 years, INSM stock has moved up by 736.4%
- POSITIVE IMPACT
Best in 1 Year
In the last 1 year, INSM has outperformed top 5 stocks with highest market-cap in its industry
- POSITIVE IMPACT
Best in 3 Years
In the last 3 years, INSM has outperformed top 5 stocks with highest market-cap in its industry
About Insmed Incorporated
| Organisation | Insmed Incorporated |
| Headquarters | 700 US Highway 202/206, Bridgewater, NJ, United States, 08807 |
| Industry | Health Technology |
| CEO | Mr. William H. Lewis J.D., M.B.A. |
| E-voting on shares | Click here to vote |
Key Management of Insmed Incorporated
Name | Title |
|---|---|
Ms. Sara M. Bonstein M.B.A. | Chief Financial Officer |
Mr. Roger Adsett M.B.A. | Chief Operating Officer |
Ms. Christie Camelio | Chief Compliance Officer |
Ms. S. Nicole Schaeffer M.B.A. | Chief People Strategy Officer |
Ms. Claire Mulhearn | Vice President of Corporate Communications |
Mr. William H. Lewis J.D., M.B.A. | President, CEO & Chairman |
Dr. Martina Flammer M.B.A., M.D. | Chief Medical Officer |
Mr. Brian K. Kaspar Ph.D. | Chief Scientific Officer |
Bryan Dunn | Vice President of Investor Relations |
Mr. Michael Alexander Smith J.D. | Chief Legal Officer & Corporate Secretary |
FAQs
What is Insmed Incorporated share price today?
Insmed Incorporated share price today is $135.97 as on at the close of the market. Insmed Incorporated share today touched a day high of $143.6 and a low of $135.73.
What is the 52 week high and 52 week low for Insmed Incorporated share?
Insmed Incorporated share touched a 52 week high of $212.75 on and a 52 week low of $60.4 on . Insmed Incorporated stock price today i.e. is closed at $135.97,which is 36.09% down from its 52 week high and 125.12% up from its 52 week low.
What is Insmed Incorporated's market capitalisation today?
Insmed Incorporated market capitalisation is $0.03T as on .
How to invest in Insmed Incorporated Stock (INSM) from India?
- Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
- Step 2: Search for Insmed Incorporated on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Insmed Incorporated Shares that will get you 0.0110 shares as per Insmed Incorporated share price of $135.97 per share as on March 21, 2026 at 1:29 am IST.
What is the minimum amount required to buy Insmed Incorporated Stock (INSM) from India?
Indian investors can start investing in Insmed Incorporated (INSM) shares with as little as ₹93.652 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹936.52 in Insmed Incorporated stock (as per the Rupee-Dollar exchange rate as on ).
Based on Insmed Incorporated share’s latest price of $135.97 as on March 21, 2026 at 1:29 am IST, you will get 0.0735 shares of Insmed Incorporated. Learn more about
fractional shares .
What are the returns that Insmed Incorporated has given to Indian investors in the last 5 years?
Insmed Incorporated stock has given 262.47% share price returns and 28.67% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?